How It Works
Highlights
Gulapro Limited has partnered with Pharma Trial Connect to spearhead the global go-to-market strategy for the world’s most advanced AI-driven clinical trial matching platform.
What it is: A digital health platform that simultaneously digitizes Africa’s Primary Health Care clinics and connects their patients to global clinical research — at no cost to governments
Patient Registration
Community Health Workers register patients via mobile devices
Data
Structuring
AI structures clinical data to ICD-10 standards automatically
Matching Patient Profiles
The platform matches patient profiles against 206,000+ active global trials. Research sites receive pre-screened, consent-verified referrals
Treatment Access
Pharma sponsors access treatment-naïve, genetically diverse populations they've never been able to reach
Three stakeholders win
Governments get free eCRF digitization, real-time disease surveillance, DHIS2 integration, and AI clinical decision support — offline-first, multilingual, zero cost
Research sites get a structured patient pipeline, automated trial matching, and a sustainable revenue model through a "digitize to monetize" framework
Pharma sponsors get access to diverse cohorts that make their drugs actually work for the world's population
The data stays sovereign. PII never leaves national borders. POPIA, GDPR, and ICH-GCP E6(R2) compliant by design — not afterthought.
And through our BlueCloudX partnership, every PHC staff member gets FREE globally-recognized GCP certification — building research careers locally and reducing brain drain.
1.2 billion people currently have no digitized health records.
BRIDGE™ PHC Mode is changing that — one clinic, one patient, one trial at a time.
sales@pharmatrialconnect.com | pharmatrialconnect.com